DNA X, Inc.
SONMNasdaqTechnology · Telephone & Telegraph Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | — | $50.9M | $93.6M | $69.8M | $54.6M | $64.0M |
| Operating income | −$5.4M | −$33.6M | $513,000 | −$14.3M | −$38.0M | −$29.3M |
| Net income | −$20.7M | −$33.6M | −$90,000 | −$14.1M | −$38.6M | −$29.9M |
| Total assets | $43.9M | $39.7M | $56.0M | $53.7M | $41.1M | $50.3M |
| Total liabilities | $50.6M | $45.4M | $33.7M | $33.6M | $22.5M | $21.9M |
| Equity | −$8.0M | −$5.7M | $22.4M | $20.0M | $18.6M | $28.4M |
| EPS (diluted) | $-28.58 | $-7.13 | $-0.02 | $-0.49 | $-4.08 | — |
| Shares out. | 6.3M | 43.2M | 41.0M | 19.3M | 66.3M | 20.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- 259.7%
- Return on assets
- −47.1%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 115.3%
- Debt / equity
- —
- Book value / share
- $-1.26
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -26.45distress
- Accruals / assets
- 6.5%moderate
- Piotroski F-Score
- 2/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 2 warning● 1 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 15, 2026
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2026
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Lytton Laurence WPassive (13G)May 15, 2026
- Dna Holdings Venture Inc.Activist (13D)Feb 20, 2026
- 1 Main Capital Management, LlcPassive (13G)Feb 17, 2026
- Streeterville Capital LlcPassive (13G)Jan 23, 2026
- L1 Capital Global Opportunities Master Fund, Ltd.Passive (13G)Nov 14, 2025
- Cvi Investments, Inc.Passive (13G)Nov 7, 2025
- Ajp Holding Company, LlcActivist (13D)Jun 26, 2025
- Orbic North America LlcActivist (13D)Mar 18, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 62,760 | 4.8 | -26.5% |
| Apr 30, 2026 | 85,395 | 2.7 | +168.1% |
| Apr 15, 2026 | 31,848 | 1.1 | -56.4% |
| Mar 31, 2026 | 72,972 | 1.0 | +10.3% |
| Mar 13, 2026 | 66,171 | 2.8 | +30.9% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreement · New financial obligation · Delisting / listing-standard notice · Unregistered equity saleMay 27, 2026
- Results of operationsMay 20, 2026
- Changed auditorApr 30, 2026
- Results of operationsApr 15, 2026
- Director / officer changeFeb 10, 2026
- Director / officer changeFeb 5, 2026
- Entered a material agreement · Terminated a material agreement · Completed an acquisition or disposition · Amended charter or bylaws · Regulation FD disclosure · Other material eventJan 27, 2026
- Shareholder voteDec 31, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KMay 27, 2026
- 10-QMay 20, 2026
- 8-KMay 20, 2026
- NT 10-QMay 15, 2026
- SCHEDULE 13G/AMay 15, 2026
- 10-K/AApr 30, 2026
- 8-KApr 30, 2026
- 10-KApr 15, 2026
- 8-KApr 15, 2026
- NT 10-KApr 1, 2026
- 8-K/AMar 2, 2026
- 3Feb 20, 2026
- SCHEDULE 13DFeb 20, 2026
- SCHEDULE 13G/AFeb 17, 2026
- SCHEDULE 13G/AFeb 17, 2026